Menopause: Do You Need a Blood Test — and Which Ones Help?

Usually not. Menopause is defined by the calendar — 12 consecutive months without a period, at an average age of 51 — and in a woman over 45 with hot flashes, night sweats, sleep disruption and periods spacing out or stopping, every major guideline says the diagnosis is clinical and a hormone test adds nothing. The reason is biological: in the years before the last period, FSH and estradiol swing from postmenopausal to premenopausal values within the same month, so a single "menopausal" FSH neither confirms the end of periods nor predicts when it will come, and a "normal" one does not rule the transition out.

Testing is genuinely useful in five situations. Under 45 (and especially under 40), where the question is premature or early ovarian insufficiency and the implications for bone, heart and fertility are different. After a hysterectomy with the ovaries kept, or on hormonal contraception, an IUD or a progestin, when there are no periods to read. When the symptoms could be something else — thyroid disease above all, but also anemia, depression, diabetes and medication effects. Before and during hormone therapy, to set a baseline and check the things estrogen changes. And when a woman simply wants to know where she is — a reasonable reason, as long as the result is read with its limits.

FSH (follicle-stimulating hormone). As the ovaries stop responding, the pituitary pushes FSH higher and higher. An FSH persistently above about 25–40 mIU/mL, on two samples four to six weeks apart, with a low estradiol, is the postmenopausal pattern; under 45 that is how premature ovarian insufficiency is confirmed. In perimenopause it is erratic, and on the pill or HRT it is suppressed and uninterpretable — stop combined hormonal contraception for at least six weeks before testing if the result matters, and do not stop without a plan for contraception, which is still needed until a year after the last period (two years under 50).

Estradiol. Falls to below about 30 pg/mL after menopause, but fluctuates wildly before it. On its own it tells you little; with FSH it confirms the pattern, and on transdermal estrogen therapy some clinicians use it to check absorption.

LH. Rises with FSH; adds little except to show the whole axis has shifted. AMH (anti-Müllerian hormone) reflects the remaining egg supply and falls to near-undetectable at menopause; it is the one hormone that is not thrown off by the cycle, and it is useful under 45 and in women deciding about fertility preservation — though guidelines caution against using it alone to predict the date of menopause.

Progesterone, testosterone and SHBG. Progesterone confirms whether a cycle ovulated (day 21) and falls away as cycles become anovulatory; testosterone declines gradually from the 30s rather than stepping down at menopause, and is measured with SHBG when low libido or energy is the question or testosterone therapy is being considered.

TSH and free T4. An overactive or underactive thyroid produces hot flashes, sweats, palpitations, weight change, mood and sleep problems that are indistinguishable from menopause, and thyroid disease becomes more common in exactly this decade. This is the one test every woman with menopausal symptoms should have.

Lipid panel. LDL cholesterol and triglycerides rise and HDL falls in the years around the final period, independent of age — the start of the post-menopausal rise in cardiovascular risk. A baseline now is what later decisions are measured against.

HbA1c or fasting glucose. Fat redistributes to the abdomen and insulin resistance increases after menopause; prediabetes is often first caught here.

Vitamin D (and later a bone density scan). Bone loss is fastest in the five years after the last period. Vitamin D status is the modifiable piece; the DEXA scan at 65, or earlier with risk factors, is the measurement.

CBC and ferritin when periods have been heavy or erratic — iron deficiency is a common, fixable cause of the fatigue and brain fog blamed on hormones. Liver enzymes and a metabolic panel before oral estrogen, and again if symptoms change on therapy.

FSH above 40 with estradiol below 30 on two occasions, no periods for a year, over 45: postmenopausal, as expected. The same pattern under 40 is primary ovarian insufficiency and needs a specialist conversation about hormone replacement to protect bone and heart until the usual age of menopause, and about fertility. FSH 15–25 with irregular cycles is late perimenopause: contraception is still needed, and symptoms can be treated now. Normal FSH with classic symptoms in your 40s is common early perimenopause — the test cannot see the fluctuations; treat the symptoms. A raised TSH or suppressed TSH changes the story entirely and is treated first. Rising LDL, A1c or a low vitamin D are the actionable findings most women take away from a menopause panel, whatever the hormones say.

Order online and walk into any Quest or Labcorp location with your requisition — no appointment or doctor's visit required. If you still have cycles, draw on day 2–5 of a period for FSH and estradiol; if cycles have stopped or are unpredictable, any day is fine, and a second sample four to six weeks later is what makes a high FSH meaningful. Fast 8–12 hours if a lipid panel or glucose is included. Note any hormonal contraception, HRT, or biotin supplements (biotin interferes with several hormone immunoassays; pause it for two days).

Results post to your account within one to three business days. Take them to your clinician or a menopause specialist for the therapy conversation — the decision about hormone therapy rests on symptoms, age, time since menopause and personal risk, not on the FSH number.